Nobel laureate Jennifer Doudna's team uses inverse protein folding AI to create never-before-seen genome editing enzymes.
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…
The 2026 MIT Technology Review list highlights a first-in-human personalized gene editing trial that will reshape pharmaceutical workflows and force…